HEALTH
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers – The Guardian
- ‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers The Guardian
- To Be Or Not To Be? Daily Oral Versus Long-Acting Injectable Medicines For HIV Prevention – OpEd Eurasia Review
- US Food and Drug Administration to make decision on new injectable HIV medication Lenacapavir by mid-June ABC13 Houston
- The end of the HIV epidemic is within reach Doctors Without Borders – USA
- Long-Lasting HIV Prevention Shot Headed Toward Approval The Norfolk Daily News
Source link
